Skip to main content
Log in

Ascorbate potentiates the cytotoxicity of menadione leading to an oxidative stress that kills cancer cells by a non-apoptotic caspase-3 independent form of cell death

  • Published:
Apoptosis Aims and scope Submit manuscript

Abstract

Hepatocarcinoma cells (TLT) were incubated in the presence of ascorbate and menadione, either alone or in combination. Cell death was only observed when such compounds were added simultaneously, most probably due to hydrogen peroxide (H2O2) generated by ascorbate-driven menadione redox cycling. TLT cells were particularly sensitive to such an oxidative stress due to its poor antioxidant status. DNA strand breaks were induced by this association but this process did not correspond to oligosomal DNA fragmentation (a hallmark of cell death by apoptosis). Neither caspase-3-like DEVDase activity, nor processing of procaspase-3 and cleavage of poly(ADP-ribose) polymerase (PARP) were observed in the presence of ascorbate and menadione. Cell death induced by such an association was actively dependent on protein phosphorylation since it was totally prevented by preincubating cells with sodium orthovanadate, a tyrosine phosphatase inhibitor. Finally, while H2O2, when administered as a bolus, strongly enhances a constitutive basal NF-κB activity in TLT cells, their incubation in the presence of ascorbate and menadione results in a total abolition of such a constitutive activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wu FY, Sun TP. Vitamin K3 induces cell cycle arrest and cell death by inhibiting Cdc25 phosphatase. Eur J Cancer 1999; 35: 1388-1393.

    Google Scholar 

  2. Hollensworth SB, Shen C, Sim JE, Spitz DR, Wilson GL, Ledoux SP. Glial cell type-specific responses to menadioneinduced oxidative stress. Free Rad Biol Med 2000; 28: 1161-1174.

    Google Scholar 

  3. Warren MC, Bump EA, Medeiros D, Braunhut SJ. Apoptosisinducing activity of vitamin C and vitamin K. Free Rad Biol Med 2000; 29: 537-547.

    Google Scholar 

  4. Noto V, Taper HS, Jiang YH, Janssens J, Bonte J, De Loecker W. Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. I. Synergism of combined vitamin C and K3 action. Cancer 1989; 63: 901-906.

    Google Scholar 

  5. Taper HS, Brucher JM, Fort L. Alkaline and acid nucleases activity in the tumors of the human central nervous system (histochemical study). Cancer 1971; 28: 482-490.

    Google Scholar 

  6. Taper HS. Reversibility of acid and alkaline deoxyribonuclease deficiency in malignant tumor cells. J Histochem Cytochem 1981; 29: 1053-1060.

    Google Scholar 

  7. Taper HS, Deckers CO, Deckers-Passau LO. Increase in nuclease activity as a possible means for detecting tumor cell sensitivity to anticancer agents. Cancer 1981; 47: 523-529.

    Google Scholar 

  8. De Loecker W, Janssens J, Bonte J, Taper HS. Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphtoquinone (vitamin K3) treatment on human tumor cell growth in vitro. II. Synergism with combined chemotherapy action. Anticancer Res 1993; 13: 103-106.

    Google Scholar 

  9. Taper HS, De Gerlache J, Lans M, Roberfroid M. Non-toxic potentiation of cancer chemotherapy by combined C and K3 vitamin pre-treatment. Int J Cancer 1992; 40: 575-579.

    Google Scholar 

  10. Taper HS, Roberfroid M. Non-toxic sensitization of cancer chemotherapy by combined vitamin C and K3 pretreatment in a mouse tumor resistant to oncovin. Anticancer Res 1992; 12: 1651-1654.

    Google Scholar 

  11. Taper HS, Keyeux A, Roberfroid M. Potentiation of radiotherapy by non-toxic pretreatment with combined vitamins C and K3 in mice bearing solid transplantable tumor. Anticancer Res 1996; 96: 499-503.

    Google Scholar 

  12. Gilloteaux J, Jamison JM, Venugopal M, Giammar D, Summers JL. Scanning electron microscopy and transmission electron microscopy aspects of synergistic antitumor activity of vitamin C-Vitamin K3 combinations against human prostatic carcinoma cells. Scanning Microscopy 1995; 9: 159-173.

    Google Scholar 

  13. Venugopal M, Jamison JM, Gilloteaux J, et al. Synergistic antitumor activity of vitamins C and K3 on human urologic tumor cell lines. Life Sci 1996; 59: 1389-1400.

    Google Scholar 

  14. Sakagami H, Satoh K, Hakeda Y, Kumegawa M. Apoptosisinducing activity of vitamin C and vitamin K. Cell Mol Biol 2000; 46: 129-143.

    Google Scholar 

  15. Zhang W, Negoro T, Satoh K, et al. Synergistic cytotoxic action of vitamin C and vitamin K3. Anticancer Res 2001; 21: 3439-3444.

    Google Scholar 

  16. Buc Calderon P, Cadrobbi J, Marques C, et al. Potential therapeutic application of the association of vitamins C and K3 in cancer treatment. Cur Med Chem 2002; 9: 2271-2285.

    Google Scholar 

  17. Gilloteaux J, Jamison JM, Arnold D, et al. Cancer cell necrosis by autoschizis: Synergism of antitumor activity of vitamin C: Vitamin K3 on human bladder carcinoma T24 cells. Scanning 1998; 20: 564-575.

    Google Scholar 

  18. Jamison JM, Gilloteaux J, Taper HS, Buc Calderon P, Summers JL. Autoschizis: A novel cell death. Biochem Pharmacol 2002; 63: 1773-1783.

    Google Scholar 

  19. Verrax J, Cadrobbi J, Delvaux M, et al. The association of vitamins C and K3 kills cancer cells mainly by autoschizis, a novel form of cell death. Basis for their potential use as coadjuvants in anticancer therapy. Eur J Med Chem 2003; 38: 451-457.

    Google Scholar 

  20. Naora H, Nishida T, Shindo Y, Adachi M, Naora H. Constitutively enhanced nbl expression is associated with the induction of internucleosomal DNA cleavage by actinomycin D. Biochem Biophys Res Commun 1996; 224: 258-264.

    Google Scholar 

  21. Legrand-Poels S, Bours V, Piret B, et al. Transcription factor NF-?B is activated by photosensitization generating oxidative DNA damages. J Biol Chem 1995; 270: 6925-6934.

    Google Scholar 

  22. Wrobleski F, Ladue J. Lactic deshydrogenase activity in blood. Proc Soc Exp Biol Med 1955; 90: 210-213.

    Google Scholar 

  23. McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969; 244: 6049-6055.

    Google Scholar 

  24. Baudhuin P, Beaufay H, Rahman-Li Y, et al. Tissue fractionation studies. 17. Intracellular distribution of monoamine oxidase, aspartate aminotransferase, alanine aminotransferase, D-amino acid oxidase and catalase in rat liver tissue. Biochem J 1964; 92: 179-184.

    Google Scholar 

  25. Wendel A. Glutathione peroxidase. Methods Enzymol 1981; 77: 325-333.

    Google Scholar 

  26. Lowry O, Rosebrough N, Farr L, Randall R. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 183: 265-275.

    Google Scholar 

  27. Sun Y, Oberley LW, Elwell JH, Sierra-Rivera E. Antioxidant enzyme activities in normal and transformed mouse liver cells. Int J Cancer 1989; 44: 1028-1033.

    Google Scholar 

  28. Oberley TD, Oberley LW. Antioxidant enzyme levels in cancer. Histol Histopathol 1997; 12: 525-535.

    Google Scholar 

  29. Bodansky O, Wrobleski D, Makardt B. Concentration of ascorbic acid in plasma and white cells of patients with cancer and non-cancerous chronic diseases. Cancer Res 1951; 11: 238-242.

    Google Scholar 

  30. Lloyd V, Davis PS, Emery H, Lauder H. Platelet ascorbic acid levels in normal subjects and in diseases. J Clin Pathol 1972; 25: 478-483.

    Google Scholar 

  31. May JM, Qu ZC, Li X. Ascorbic acid blunts oxidant stress due to menadione in endothelial cells. Arch Biochem Biophys 2003; 411: 136-144.

    Google Scholar 

  32. Roginsky VA, Bruchelt G, Bartuli O. Ubiquinone-0 (2,3-dimethoxy-5-methyl-1,4-benzoquinone) as effective catalyzer of ascorbate and epinephrine oxidation and damager of neuroblastoma cells. Biochem Pharmacol 1998; 55: 85-91.

    Google Scholar 

  33. Thor H, Moldeus P, Orrenius S. Metabolic activation and hepatotoxicity. Effect of cysteine, N-acetylcysteine, and methionine on glutathione biosynthesis and bromobenzene toxicity in isolated rat hepatocytes. Arch Biochem Biophys 1979; 192: 405-413.

    Google Scholar 

  34. Gant TW, Rao DN, Mason RP, Cohen GM. Redox cycling and sulphydryl arylation; their relative importance in the mechanism of quinone cytotoxicity to isolated hepatocytes. Chem Biol Interactions 1988; 65: 157-173.

    Google Scholar 

  35. Grant TW, Doherty MD, Odowole D, Sales KD, Cohen GM. Semiquinone anion radicals formed by the reaction of quinones with glutathione or amino acids. FEBS Lett 1986; 201: 296-300.

    Google Scholar 

  36. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284: 555-556.

    Google Scholar 

  37. Uren AG, Vaux DL. Molecular and clinical aspects of apoptosis. Pharmacol Ther 1996; 72: 37-50.

    Google Scholar 

  38. Cohen GM. Caspases: The executioners of apoptosis. Biochem J 1997; 325: 1-16.

    Google Scholar 

  39. Nicholson DW, Thornberry NA. Caspases: Killer proteases. Trends Biochem Sci 1997; 22: 299-306.

    Google Scholar 

  40. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-1312.

    Google Scholar 

  41. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75: 241-251.

    Google Scholar 

  42. Lindenboim L, Haviv R, Stein R. Inhibition of drug-induced apoptosis by survival factors in PC12 cells. J Neurochem 1995; 64: 1054-1063.

    Google Scholar 

  43. Castedo M, Hirsch T, Susin SA, et al. Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J Immunol 1996; 157: 512-521.

    Google Scholar 

  44. Sata N, Klonowski-Stumpe H, Han B, Haussinger D, Niederau C. Menadione induces both necrosis and apoptosis in rat pancreatic acinar AR4-2J cells. Free Rad Biol Med 1997; 23: 844-850.

    Google Scholar 

  45. Sakagami H, Satoh K. Modulating factors of radical intensity and cytotoxic activity of ascorbate. Anticancer Res 1997; 17: 3513-3520.

    Google Scholar 

  46. Hampton MB, Orrenius S. Dual regulation of caspase activity by hydrogen peroxide: Implications for apoptosis. FEBS Lett 1997; 414: 552-556.

    Google Scholar 

  47. Li J, Billiar TR, Talanian RV, Kim YM. Nitric Oxide Reversibly Inhibits Seven Members of the Caspase Family via S-Nitrosylation. Biochem Biophys Res Commun 1997; 240: 419-424.

    Google Scholar 

  48. Bratton SB, Cohen GM. Apoptotic death sensor: An organelle's alter ego? Trends Pharmacol Sci 2001; 22: 306-315.

    Google Scholar 

  49. Gauld SB, Blair D, Moss CA, Reid SD, Harnett MM. Differential roles for extracellularly regulated kinase-mitogen-activated protein kinase in B cell antigen receptor-induced apoptosis and CD40-mediated rescue of WEHI-231 immature B cell. J Immunol 2002; 168: 3855-3864.

    Google Scholar 

  50. Pimentel B, Rodriguez-Bolardo L, Hernandez C, Carrera AC. A role for phosphoinositide 3-kinase in the control of cell division and survival during retinal development. Develop Biol 2002; 247: 295-306.

    Google Scholar 

  51. Huyer G, Liu S, Kelly J, et al. Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J Biol Chem 1997; 272: 843-851.

    Google Scholar 

  52. Watanabe T, Suzuki T, Umezawa Y, et al. Structure-activity relationship and rational design of 3,4-dephostatin derivatives as protein tyrosine phosphatase inhibitors. Tetrahedron 2000; 56: 741-752.

    Google Scholar 

  53. Wang CY, Mayo MW, Baldwin AS Jr. TNF-and cancer therapyinduced apoptosis: Potentiation by inhibition of NF-kappaB. Science 1996; 274: 784-787.

    Google Scholar 

  54. Aggarwal BB. Apoptosis and nuclear factor-kappa B: A tale of association and dissociation. Biochem Pharmacol 2000; 60: 1033-1039.

    Google Scholar 

  55. Chen Q, Cederbaum AI. Menadione cytotoxicity to Hep G2 cells and protection by activation of nuclear factor-kappaB. Mol Pharmacol 1997; 52: 648-657.

    Google Scholar 

  56. Bharti AC, Aggarwal BB. Nuclear factor-kappa B and cancer: Its role in prevention and therapy. Biochem Pharmacol 2002; 64: 883-888.

    Google Scholar 

  57. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 1991; 10: 2247-2258.

    Google Scholar 

  58. Chaturvedi MM, Kumar A, Darnay BG, Chainy BG, Aggarwal S, Aggarwal BB. Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappaB activation, IkappaBalpha phosphorylation, and degradation. J Biol Chem 1997; 272: 30129-30134.

    Google Scholar 

  59. Bowie A, O'Neill LA. Oxidative stress and nuclear factorkappaB activation: A reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 2000; 59: 13-23.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pedro Buc Calderon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verrax, J., Cadrobbi, J., Marques, C. et al. Ascorbate potentiates the cytotoxicity of menadione leading to an oxidative stress that kills cancer cells by a non-apoptotic caspase-3 independent form of cell death. Apoptosis 9, 223–233 (2004). https://doi.org/10.1023/B:APPT.0000018804.26026.1a

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:APPT.0000018804.26026.1a

Navigation